Samuel Goldman, MD, MPH

PROF OF CLIN-HCOMP

VA Medicine Home

My work focuses on environmental risk factors for Parkinson’s disease and other neurodegenerative disorders. Among these are pesticides, solvents, smoking and traumatic brain injury, the microbiome, and the interaction of these factors with genetic susceptibility factors.

Education
05/1994 - Preventive Medicine, University of California-Berkeley
MPH, 05/1993 - Environmental Health Science, University of California-Berkeley
06/1988 - Internal Medicine, Mt. Zion Hospital
MD, 05/1987 - Medicine, University of Texas, Houston
BS, 08/1982 - Psychology, University of Michigan
Publications

  1. Dorsey ER, Kinel D, Pawlik ME, Zafar M, Lettenberger SE, Coffey M, Auinger P, Hylton KL, Shaw CW, Adams JL, Barbano R, Braun MK, Schwarz HB, Lawrence BP, Kieburtz K, Tanner CM, de Miranda BR, Goldman SM. Dry-Cleaning Chemicals and a Cluster of Parkinson's Disease and Cancer: A Retrospective Investigation. Movement disorders : official journal of the Movement Disorder Society 2024. PMID: 38389433


  2. Karabayir I, Gunturkun F, Butler L, Goldman SM, Kamaleswaran R, Davis RL, Colletta K, Chinthala L, Jefferies JL, Bobay K, Ross GW, Petrovitch H, Masaki K, Tanner CM, Akbilgic O. Externally validated deep learning model to identify prodromal Parkinson's disease from electrocardiogram. Scientific Reports 2023. PMID: 37516770


  3. Goldman SM, Weaver FM, Stroupe KT, Cao L, Gonzalez B, Colletta K, Brown EG, Tanner CM. Risk of Parkinson Disease Among Service Members at Marine Corps Base Camp Lejeune. JAMA neurology 2023. PMID: 37184848


  4. Soman K, Nelson CA, Cerono G, Goldman SM, Baranzini SE, Brown EG. Early detection of Parkinson's disease through enriching the electronic health record using a biomedical knowledge graph. Frontiers in medicine 2023. PMID: 37250641


  5. Dorsey ER, Zafar M, Lettenberger SE, Pawlik ME, Kinel D, Frissen M, Schneider RB, Kieburtz K, Tanner CM, De Miranda BR, Goldman SM, Bloem BR. Trichloroethylene: An Invisible Cause of Parkinson's Disease? Journal of Parkinson's disease 2023. PMID: 36938742


  6. Meghan Pawlik, Maryam Zafar, Samantha Lettenberger, Madeleine Coffey, Aayush Sarkar, Caroline Tanner, Samuel Goldman, Briana De Miranda, Karl Kieburtz, Daniel Kinel, E. Ray Dorsey. Dry Cleaning & Parkinson’s Disease: Evaluation of a Potential Cluster (P11-11.001). Neurology 2022. PMID:


  7. Nijee Luthra, Ethan Brown, Samuel Goldman, Rafael Zuzuarregui, Trisha Hue, Christopher Schambach, Ian Bledsoe, Michael Schwarzschild, E. Ray Dorsey, Alberto Espay, Irene Litvan, Nikolaus McFarland, Kyle Mitchell, David Standaert, James Beck, Helen Rowbotham, Cheryl Meng, Jacque Perkins, Primi Ranola, Raymundo Picos, Dana Kriesel, Kenneth Lyles, Steve Cummings, Caroline Tanner. Enhancing Pandemic-Sensitive Recruitment Strategies for a Remote, Randomized Placebo-Controlled Trial for Fracture Prevention in Patients with Neurodegenerative Parkinsonisms (P1-1.Virtual). Neurology 2022. PMID:


  8. Karabayir I, Butler L, Goldman SM, Kamaleswaran R, Gunturkun F, Davis RL, Ross GW, Petrovitch H, Masaki K, Tanner CM, Tsivgoulis G, Alexandrov AV, Chinthala LK, Akbilgic O. Predicting Parkinson's Disease and Its Pathology via Simple Clinical Variables. TO REMOVE 2021. PMID: 34602502


  9. De Miranda BR, Goldman SM, Miller GW, Greenamyre JT, Dorsey ER. Preventing Parkinson's Disease: An Environmental Agenda. TO REMOVE 2021. PMID: 34719434


  10. Omberg L, Chaibub Neto E, Perumal TM, Pratap A, Tediarjo A, Adams J, Bloem BR, Bot BM, Elson M, Goldman SM, Kellen MR, Kieburtz K, Klein A, Little MA, Schneider R, Suver C, Tarolli C, Tanner CM, Trister AD, Wilbanks J, Dorsey ER, Mangravite LM. Remote smartphone monitoring of Parkinson's disease and individual response to therapy. TO REMOVE 2021. PMID: 34373643


  11. Carricarte Naranjo C, Marras C, Visanji NP, Cornforth DJ, Sanchez-Rodriguez L, Schüle B, Goldman SM, Estévez M, Stein PK, Lang AE, Jelinek HF, Machado A. Short-term deceleration capacity of heart rate: a sensitive marker of cardiac autonomic dysfunction in idiopathic Parkinson's disease. TO REMOVE 2021. PMID: 34251546


  12. Tanner CM, Cummings SR, Schwarzschild MA, Brown EG, Dorsey ER, Espay AJ, Galifianakis NB, Goldman SM, Litvan I, Luthra N, McFarland NR, Mitchell KT, Standaert DG, Bauer DC, Greenspan SL, Beck JC, Lyles KW. The TOPAZ study: a home-based trial of zoledronic acid to prevent fractures in neurodegenerative parkinsonism. NPJ Parkinson's disease 2021. PMID: 33649343


  13. Brown EG, Goldman SM. Modulation of the Microbiome in Parkinson's Disease: Diet, Drug, Stool Transplant, and Beyond. TO REMOVE 2020. PMID: 33034846


  14. Karabayir I, Goldman SM, Pappu S, Akbilgic O. Gradient boosting for Parkinson's disease diagnosis from voice recordings. TO REMOVE 2020. PMID: 32933493


  15. Karabayir I, Goldman SM, Pappu S, Akbilgic O. Gradient boosting for Parkinson’s disease diagnosis from voice recordings TO REMOVE 2020. PMID:


  16. San Luciano M, Tanner CM, Meng C, Marras C, Goldman SM, Lang AE, Tolosa E, Schüle B, Langston JW, Brice A, Corvol JC, Goldwurm S, Klein C, Brockman S, Berg D, Brockmann K, Ferreira JJ, Tazir M, Mellick GD, Sue CM, Hasegawa K, Tan EK, Bressman S, Saunders-Pullman R, Michael J. Fox Foundation LRRK2 Cohort Consortium. Nonsteroidal Anti-inflammatory Use and LRRK2 Parkinson's Disease Penetrance. TO REMOVE 2020. PMID: 32662532


  17. Akbilgic O, Kamaleswaran R, Mohammed A, Ross GW, Masaki K, Petrovitch H, Tanner CM, Davis RL, Goldman SM. Electrocardiographic changes predate Parkinson's disease onset. TO REMOVE 2020. PMID: 32647196


  18. Brown EG, Goldman SM. Traumatic brain injury and α-synuclein: Proceed with caution. TO REMOVE 2020. PMID: 31992678


  19. Brown EG, Chahine LM, Goldman SM, Korell M, Mann E, Kinel DR, Arnedo V, Marek KL, Tanner CM. The Effect of the COVID-19 Pandemic on People with Parkinson's Disease. TO REMOVE 2020. PMID: 32925107


  20. LaHue SC, Albers K, Goldman S, Lo RY, Gu Z, Leimpeter A, Fross R, Comyns K, Marras C, de Kleijn A, Smit R, Katz M, Ozelius LJ, Bressman S, Saunders-Pullman R, Comella C, Klingman J, Nelson LM, Van Den Eeden SK, Tanner CM. Cervical dystonia incidence and diagnostic delay in a multiethnic population. TO REMOVE 2019. PMID: 31774238


  21. Carricarte Naranjo C, Marras C, Visanji NP, Cornforth DJ, Sanchez-Rodriguez L, Schüle B, Goldman SM, Estévez M, Stein PK, Lang AE, Jelinek HF, Machado A. Increased markers of cardiac vagal activity in leucine-rich repeat kinase 2-associated Parkinson's disease. TO REMOVE 2019. PMID: 31444591


  22. Gatz M, Plassman BL, Tanner CM, Goldman SM, Swan GE, Chanti-Ketterl M, Walters EE, Butler DA. The NAS-NRC Twin Registry and Duke Twins Study of Memory in Aging: An Update. TO REMOVE 2019. PMID: 31354124


  23. Goldman SM, Tanner CM. Rotenone and Parkinson's Disease: Reduced Sensitivity in Females. TO REMOVE 2019. PMID: 31161209


  24. Marras C, Canning CG, Goldman SM. Environment, lifestyle, and Parkinson's disease: Implications for prevention in the next decade. TO REMOVE 2019. PMID: 31091353


  25. Goldman SM, Marek K, Ottman R, Meng C, Comyns K, Chan P, Ma J, Marras C, Langston JW, Ross GW, Tanner CM. Concordance for Parkinson's disease in twins: A 20-year update. TO REMOVE 2019. PMID: 30786044


  26. Leng Y, Goldman SM, Cawthon PM, Stone KL, Ancoli-Israel S, Yaffe K. Excessive daytime sleepiness, objective napping and 11-year risk of Parkinson's disease in older men. International journal of epidemiology 2018. PMID: 29873737


  27. Brown EG, Goldman SM, Tanner CM. Mendel and urate: Acid test or random noise? TO REMOVE 2018. PMID: 30100365


  28. Ethan G. Brown, Caroline M. Tanner, Samuel M. Goldman. The Microbiome in Neurodegenerative Disease. TO REMOVE 2018. PMID:


  29. Y Leng, S M Goldman, P Cawthon, K Stone, S Ancoli-Israel, K Yaffe. 1018 Excessive Daytime Sleepiness, Objectively Measured Napping And 11-year Risk Of Parkinson’S Disease In Community-dwelling Older Men. TO REMOVE 2018. PMID:


  30. Samuel Goldman, Ahro Kim, Cheryl Meng, Kathleen Comyns, Helen Petrovitch, Caroline Tanner, Robert Abbott, G. Webster Ross. Heart Rate Variability (HRV) from a 10-second Electrocardiogram (ECG) in Parkinson’s Disease (PD) and Control (P1.037). Neurology 2018. PMID:


  31. Goldman SM, Musgrove RE, Jewell SA, Di Monte DA. Advances in Neurotoxicology. Aschner M & Costa LG, eds TO REMOVE 2017. PMID:


  32. Ciesielska A, Samaranch L, San Sebastian W, Dickson DW, Goldman S, Forsayeth J, Bankiewicz KS. Depletion of AADC activity in caudate nucleus and putamen of Parkinson's disease patients; implications for ongoing AAV2-AADC gene therapy trial. TO REMOVE 2017. PMID: 28166239


  33. Visanji NP, Bhudhikanok GS, Mestre TA, Ghate T, Udupa K, AlDakheel A, Connolly BS, Gasca-Salas C, Kern DS, Jain J, Slow EJ, Faust-Socher A, Kim S, Azhu Valappil R, Kausar F, Rogaeva E, William Langston J, Tanner CM, Schüle B, Lang AE, Goldman SM, Marras C. Heart rate variability in leucine-rich repeat kinase 2-associated Parkinson's disease. TO REMOVE 2017. PMID: 28071824


  34. Samuel M. Goldman, Ruth E. Musgrove, Sarah A. Jewell, Donato A. Di Monte. Chapter Three Pesticides and Parkinson's Disease: Current Experimental and Epidemiological Evidence. TO REMOVE 2017. PMID:


  35. Erica Byrd, Kathleen Albers, Samuel Goldman, Jeffrey Klingman, Raymond Lo, Connie Marras, Amethyst Leimpeter, Robin Fross, Kathleen Comyns, Zhuqin Gu, Maya Katz, Laurie Ozelius, Susan Bressman, Rachel Saunders-Pullman, Cynthia Comella, Lorene Nelson, Stephen Van Den Eeden, Caroline Tanner. Blepharospasm in a Multiethnic Population (P3.348). Neurology 2016. PMID:


  36. Samuel Goldman, Freya Kamel, Chen Meng, Monica Korell, Kathleen Comyns, David Umbach, Jane Hoppin, G. Ross, Connie Marras, Meike Kasten, Anabel Chade, Aaron Blair, Caroline Tanner. Polychlorinated Biphenyls (PCBs) and Parkinson's Disease (PD): Effect Modification by Membrane Transporter Variants (S32.004). Neurology 2016. PMID:


  37. Sara LaHue, Kathleen Albers, Samuel Goldman, Amethyst Leimpeter, Stephen Van Den Eeden, Caroline Tanner. Prodromal Diagnoses in the Electronic Medical Record (EMR) Differ in Parkinson’s Disease (PD), Dementia with Lewy Bodies (DLB), Multiple System Atrophy (MSA), and Progressive Supranuclear Palsy (PSP) (P3.347). Neurology 2016. PMID:


  38. Goldman, SM, Tanner, CM. Parkinson’s Disease and Movement Disorders. Jankovic J & Tolosa E, eds TO REMOVE 2016. PMID:


  39. Goldman SM. A diagnostic algorithm for Parkinson's disease: what next? TO REMOVE 2015. PMID: 26271531


  40. Goldman SM, Umbach DM, Kamel F, Tanner CM. Head injury, α-synuclein Rep1 and Parkinson's disease: a meta-analytic view of gene-environment interaction. TO REMOVE 2015. PMID: 26060929


  41. Sara LaHue, Kathleen Albers, Samuel Goldman, Jeffrey Klingman, Raymond Lo, Connie Marras, Amethyst Leimpeter, Robin Fross, Kathleen Comyns, Zhuqin Gu, Maya Katz, Laurie Ozelius, Susan Bressman, Rachel Saunders-Pullman, Cynthia Comella, Lorene Nelson, Stephen Van Den Eeden, Caroline Tanner. Cervical dystonia (CD) incidence and diagnostic delay in a multiethnic health maintenance organization. (S36.004). Neurology 2015. PMID:


  42. Gardner RC, Burke JF, Nettiksimmons J, Goldman S, Tanner CM, Yaffe K. Traumatic brain injury in later life increases risk for Parkinson disease. Annals of neurology 2015. PMID: 25726936


  43. Beecham GW, Dickson DW, Scott WK, Martin ER, Schellenberg G, Nuytemans K, Larson EB, Buxbaum JD, Trojanowski JQ, Van Deerlin VM, Hurtig HI, Mash DC, Beach TG, Troncoso JC, Pletnikova O, Frosch MP, Ghetti B, Foroud TM, Honig LS, Marder K, Vonsattel JP, Goldman SM, Vinters HV, Ross OA, Wszolek ZK, Wang L, Dykxhoorn DM, Pericak-Vance MA, Montine TJ, Leverenz JB, Dawson TM, Vance JM. PARK10 is a major locus for sporadic neuropathologically confirmed Parkinson disease. TO REMOVE 2015. PMID: 25663231


  44. Kalia LV, Lang AE, Hazrati LN, Fujioka S, Wszolek ZK, Dickson DW, Ross OA, Van Deerlin VM, Trojanowski JQ, Hurtig HI, Alcalay RN, Marder KS, Clark LN, Gaig C, Tolosa E, Ruiz-Martínez J, Marti-Masso JF, Ferrer I, López de Munain A, Goldman SM, Schüle B, Langston JW, Aasly JO, Giordana MT, Bonifati V, Puschmann A, Canesi M, Pezzoli G, Maues De Paula A, Hasegawa K, Duyckaerts C, Brice A, Stoessl AJ, Marras C. Clinical correlations with Lewy body pathology in LRRK2-related Parkinson disease. TO REMOVE 2015. PMID: 25401511


  45. Furlong M, Tanner CM, Goldman SM, Bhudhikanok GS, Blair A, Chade A, Comyns K, Hoppin JA, Kasten M, Korell M, Langston JW, Marras C, Meng C, Richards M, Ross GW, Umbach DM, Sandler DP, Kamel F. Protective glove use and hygiene habits modify the associations of specific pesticides with Parkinson's disease. TO REMOVE 2014. PMID: 25461423


  46. Melissa Furlong*, Caroline Tanner, Samuel Goldman, Grace Bhudhikanok, Aaron Blair, Anabel Chade, Kathleen Comyns, Monica Korell, Jane Hoppin, Meike Kasten, J William Langston, Connie Marras, Cheryl Meng, Marie Richards, G Webster Ross, David Umbach, Dale Sandler, Freya Kamel. Protective Glove Use and Workplace Hygiene Practices Modify Associations between Pesticides and Parkinson's Disease. TO REMOVE 2014. PMID:


  47. Goldman SM, Whisnant-Cash S. Trichloroethylene: Toxicity and Health Risks TO REMOVE 2014. PMID:


  48. Tanner CM, Goldman SM, Ross GW, Grate SJ. The disease intersection of susceptibility and exposure: chemical exposures and neurodegenerative disease risk. TO REMOVE 2014. PMID: 24924672


  49. Goldman SM, Kamel F, Ross GW, Jewell SA, Marras C, Hoppin JA, Umbach DM, Bhudhikanok GS, Meng C, Korell M, Comyns K, Hauser RA, Jankovic J, Factor SA, Bressman S, Lyons KE, Sandler DP, Langston JW, Tanner CM. Peptidoglycan recognition protein genes and risk of Parkinson's disease. TO REMOVE 2014. PMID: 24838182


  50. Samuel Goldman, Birgitt Schuele, Grace Bhudhikanok, Stephanie Cash, Monica Korell, Yamah Amiri, Chen Meng, Kathleen Comyns, Dolores Guest, Linda Rees, Sam Kim, Farah Kausar, Sakunthala Sundarrajan, Emily Drabant Conley, Nicholas Eriksson, Grace Liang, Melanie Brandabur, James Tetrud, J Langston, Caroline Tanner. Heart Rate Variability in LRRK2 Parkinson’s Disease (S37.004). Neurology 2014. PMID:


  51. Samuel M. Goldman, Stephanie Whisnant Cash. Role of Trichloroethylene in Parkinson’s Disease. TO REMOVE 2014. PMID:


  52. Kamel F, Goldman SM, Umbach DM, Chen H, Richardson G, Barber MR, Meng C, Marras C, Korell M, Kasten M, Hoppin JA, Comyns K, Chade A, Blair A, Bhudhikanok GS, Webster Ross G, William Langston J, Sandler DP, Tanner CM. Dietary fat intake, pesticide use, and Parkinson's disease. TO REMOVE 2013. PMID: 24120951


  53. Goldman SM. Environmental toxins and Parkinson's disease. TO REMOVE 2013. PMID: 24050700


  54. Samuel M. Goldman. Parkinson's Disease. TO REMOVE 2013. PMID:


  55. Caroline Tanner, Kathleen Albers, Samuel Goldman, Jeffrey Klingman, Raymond Lo, Connie Marras, Amethyst Leimpeter, Robin Fross, Zhuqin Gu, Robin Smit, Annelie de Kleijn, Grace Bhudhikanok, Laurie Ozelius, Susan Bressman, Rachel Saunders-Pullman, Cynthia Comella, Lorene Nelson, Stephen Van Den Eeden. Incidence of Primary Torsion Dystonia in a Multiethnic Population (S53.001). Neurology 2013. PMID:


  56. Samuel Goldman, Sarah Jewell, Cheryl Meng, Web Ross, Anabel Chade, Meike Kasten, Grace Bhudhikanok, Kathleen Comyns, Monica Korell, J. Langston, Caroline Tanner. Parkinson's Disease Risk Is Associated with Variants in Genes That Bind Bacterial Cell-Wall Peptidoglycan (P05.051). Neurology 2013. PMID:


  57. Ronald Pfeiffer, Zbigniew Wszolek, Manuchair Ebadi, Samuel Goldman. Industrial and Occupational Exposures and Parkinson Disease. TO REMOVE 2012. PMID:


  58. Goldman SM, Kamel F, Ross GW, Bhudhikanok GS, Hoppin JA, Korell M, Marras C, Meng C, Umbach DM, Kasten M, Chade AR, Comyns K, Richards MB, Sandler DP, Blair A, Langston JW, Tanner CM. Genetic modification of the association of paraquat and Parkinson's disease. TO REMOVE 2012. PMID: 23045187


  59. Samuel M. Goldman, Patricia J. Quinlan, G. Webster Ross, Connie Marras, J. William Langston, Caroline M. Tanner. Reply. TO REMOVE 2012. PMID:


  60. S. Goldman, F. Kamel, G. Bhudhikanok, M. Korell, C. Meng, K. Comyns, D. Umbach, J. Hoppin, W. Ross, C. Marras, M. Kasten, A. Chade, D. Sandler, A. Blair, J. Langston, C. Tanner. Paraquat Use Modifies the Association of Head Injury and Parkinson's Disease (PD) (S42.003). TO REMOVE 2012. PMID:


  61. F. Kamel, G. Richardson, D. Umbach, M. Richards, G. Bhudhikanok, A. Blair, A. Chade, K. Comyns, S. Goldman, J. Hoppin, M. Kasten, M. Korell, C. Marras, C. Meng, G. Ross, J. Langston, D. Sandler, C. Tanner. Risk of Parkinson's Disease (PD) Associated with the Herbicide Paraquat Is Attenuated by High Dietary Intake of Polyunsaturated Fatty Acids (PUFAs) (S42.004). TO REMOVE 2012. PMID:


  62. C. Tanner, K. Albers, S. Goldman, R. Fross, A. Leimpeter, J. Klingman, S. Van Den Eeden. Seborrheic Dermatitis and Risk of Future Parkinson's Disease (PD) (S42.001). TO REMOVE 2012. PMID:


  63. Marras C, Goldman SM. Genetics meets environment: evaluating gene-environment interactions in neurologic diseases. TO REMOVE 2012. PMID: 22266892


  64. S.M. Goldman. 2.17.3 TRICHLOROETHYLENE (TCE) EXPOSURE AND PARKINSON'S DISEASE (PD) RISK. TO REMOVE 2012. PMID:


  65. Goldman SM, Kamel F, Ross GW, Jewell SA, Bhudhikanok GS, Umbach D, Marras C, Hauser RA, Jankovic J, Factor SA, Bressman S, Lyons KE, Meng C, Korell M, Roucoux DF, Hoppin JA, Sandler DP, Langston JW, Tanner CM. Head injury, α-synuclein Rep1, and Parkinson's disease. TO REMOVE 2012. PMID: 22275250


  66. Goldman SM, Quinlan PJ, Ross GW, Marras C, Meng C, Bhudhikanok GS, Comyns K, Korell M, Chade AR, Kasten M, Priestley B, Chou KL, Fernandez HH, Cambi F, Langston JW, Tanner CM. Solvent exposures and Parkinson disease risk in twins. TO REMOVE 2011. PMID: 22083847


  67. Do CB, Tung JY, Dorfman E, Kiefer AK, Drabant EM, Francke U, Mountain JL, Goldman SM, Tanner CM, Langston JW, Wojcicki A, Eriksson N. Web-based genome-wide association study identifies two novel loci and a substantial genetic component for Parkinson's disease. TO REMOVE 2011. PMID: 21738487


  68. Tanner CM, Kamel F, Ross GW, Hoppin JA, Goldman SM, Korell M, Marras C, Bhudhikanok GS, Kasten M, Chade AR, Comyns K, Richards MB, Meng C, Priestley B, Fernandez HH, Cambi F, Umbach DM, Blair A, Sandler DP, Langston JW. Rotenone, paraquat, and Parkinson's disease. TO REMOVE 2011. PMID: 21269927


  69. Valappil RA, Black JE, Broderick MJ, Carrillo O, Frenette E, Sullivan SS, Goldman SM, Tanner CM, Langston JW. Exploring the electrocardiogram as a potential tool to screen for premotor Parkinson's disease. TO REMOVE 2010. PMID: 20976736


  70. Goldman SM. Trichloroethylene and Parkinson's disease: dissolving the puzzle. TO REMOVE 2010. PMID: 20518596


  71. S. Goldman. O.006 Epidemiology of dystonia. TO REMOVE 2009. PMID:


  72. Freya Kamel, Grace Bhudhikanok, Aaron Blair, Samuel Goldman, Jane Hoppin, Monica Korell, J William Langston, Marie Richards, G Webster Ross, Dale Sandler, David Umbach, Caroline Tanner. Pesticide Exposure and Parkinson's Disease (PD) in the Agricultural Health Study (AHS). TO REMOVE 2009. PMID:


  73. Bronstein J, Carvey P, Chen H, Cory-Slechta D, DiMonte D, Duda J, English P, Goldman S, Grate S, Hansen J, Hoppin J, Jewell S, Kamel F, Koroshetz W, Langston JW, Logroscino G, Nelson L, Ravina B, Rocca W, Ross GW, Schettler T, Schwarzschild M, Scott B, Seegal R, Singleton A, Steenland K, Tanner CM, Van Den Eeden S, Weisskopf M. Meeting report: consensus statement-Parkinson's disease and the environment: collaborative on health and the environment and Parkinson's Action Network (CHE PAN) conference 26-28 June 2007. TO REMOVE 2008. PMID: 19165397


  74. Kamel F, Tanner C, Umbach D, Hoppin J, Alavanja M, Blair A, Comyns K, Goldman S, Korell M, Langston J, Ross G, Sandler D. Pesticide exposure and self-reported Parkinson's disease in the agricultural health study. TO REMOVE 2006. PMID: 17116648


  75. Goldman SM, Tanner CM, Oakes D, Bhudhikanok GS, Gupta A, Langston JW. Head injury and Parkinson's disease risk in twins. TO REMOVE 2006. PMID: 16718702


  76. Goldman SM, Tanner CM, Olanow CW, Watts RL, Field RD, Langston JW. Occupation and parkinsonism in three movement disorders clinics. TO REMOVE 2005. PMID: 16162857


  77. Marras C, Goldman S, Smith A, Barney P, Aston D, Comyns K, Korell M, Langston JW, Ross GW, Tanner CM. Smell identification ability in twin pairs discordant for Parkinson's disease. TO REMOVE 2005. PMID: 15719425


  78. Hollblad-Fadiman K, Goldman SM. American College of Preventive Medicine practice policy statement: screening for Chlamydia trachomatis. TO REMOVE 2003. PMID: 12657352


  79. Tanner CM, Goldman SM, Aston DA, Ottman R, Ellenberg J, Mayeux R, Langston JW. Smoking and Parkinson's disease in twins. TO REMOVE 2002. PMID: 11865136


  80. Tanner CM, Goldman SM, Lyons KE, Aston DA, Tetrud JW, Welsh MD, Langston JW, Koller WC. Essential tremor in twins: an assessment of genetic vs environmental determinants of etiology. TO REMOVE 2001. PMID: 11673577


  81. Tanner CM, Ottman R, Goldman SM, Ellenberg J, Chan P, Mayeux R, Langston JW. Parkinson disease in twins: an etiologic study. TO REMOVE 1999. PMID: 9929087


  82. Tanner CM, Goldman SM. Epidemiology of Tourette syndrome. TO REMOVE 1997. PMID: 9115469


  83. Zola J, Smith N, Goldman S, Woodruff BA. Attitudes and educational practices of obstetric providers regarding infant hepatitis B vaccination. TO REMOVE 1997. PMID: 8990439


  84. Tanner CM, Goldman SM. Epidemiology of Parkinson's disease. TO REMOVE 1996. PMID: 8827174


  85. Tanner CM, Goldman SM. Epidemiology of movement disorders. TO REMOVE 1994. PMID: 7952243


  86. Potter WZ, Hsiao JK, Goldman SM. Effects of renal clearance on plasma concentrations of homovanillic acid. Methodologic cautions. TO REMOVE 1989. PMID: 2730280